Pudgy Penguins' Defense of the $0.00122 Support Level May Trigger a Bullish Breakout
- Pudgy Penguins (PENGU) trades near $0.005–$0.01 support zone amid oversold RSI (30) and declining bearish AO, signaling potential reversal. - Analysts label current price a "steal buy" due to weakening sell momentum and bullish divergence, with $0.015–$0.023 long-term targets. - Edgen+ partnership expansion drove 10% price surge and 50% volume spike to $188M, enhancing token utility via lifestyle platform integration. - Growing social media adoption and cultural visibility boost meme coin interest, thoug
Pudgy Penguins (PENGU) is at a pivotal point as its value drops into oversold levels, drawing fresh attention from both traders and market experts. The token is currently hovering around a significant support area between $0.005 and $0.01, and both technical signals and recent strategic moves indicate a possible trend reversal may be approaching. One market analyst has even described the current price as a "bargain buy,"
The RSI for
Optimism is further fueled by Pudgy Penguins' recent partnership expansion with Edgen+. The second phase of this collaboration, revealed on November 24, brings exclusive perks to more than 250,000 PENGU holders,
Market sentiment is also evolving. Pudgy Penguins' expanding cultural influence, with celebrities embracing its branding and greater exposure across social platforms, has sparked renewed interest during a period that is usually slow for meme coins
Nonetheless, there are still risks. If the price falls below the $0.005–$0.01 support band, recovery could be postponed, leading to further consolidation.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
PetVivo's transition to AI-powered SaaS disrupts MedTech valuations, aiming for a 15-fold growth
- PetVivo launched PetVivo.ai, an AI platform slashing veterinary client acquisition costs by 90% through automated lead generation and engagement. - The platform cuts costs to $42.53 (vs. $80–$400) and enables 80–90% gross margins, shifting the company from low-margin medical devices to a SaaS model. - With 12 patents, 1,200 distributors, and $360M 5-year ARR projections, PetVivo aims to re-rate its valuation from 1–2x to 15x revenue multiples like C3.ai.

Astar (ASTR) Price Rally: How Cross-Chain Blockchain Solutions Attract Institutional Interest
- Astar (ASTR) gains institutional traction as blockchain interoperability drives adoption, with $3.16M investment in October 2025. - Technical upgrades like Astar 2.0's 150,000 TPS capacity and partnerships with Sony/Japan Airlines enhance cross-chain utility. - Q3 2025 TVL of $2.38M contrasts with DeFi's $11.96B decline, highlighting Astar's deflationary tokenomics and institutional appeal. - Strategic positioning as a multichain bridge validates ASTR's role in connecting traditional finance with decentr

DOGE Builds 12h Wedge as Chart Signals an 80 to 90% Upside Zone

XLM Tracks 51 and 52 Bar Cycles With Price Near $0.618 and $0.786 Zones
